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Abstract
Background: Endothelial adhesion molecules ICAM-1 (CD54) and VCAM-1 (CD106) mediate cellular adhesion and
transcellular migration. Cell adhesion and diapedesis have a key role in the course of shock and sepsis. During
severe sepsis, adrenoceptor agonist levels may be increased due to endogenous production or due to intensive
care treatment. As yet, the influence of b1o rb2 agonists on adhesion molecule formation on endothelial cells has
remained unclear.
Methods: Cultured human umbilical vein endothelial cells were stimulated with E. coli. Following bacterial
stimulation the cells were incubated with either b2 receptor agonist terbutaline or b1 agonist norepinephrine.
ICAM-1 and VCAM-1 expression were examined using flow cytometry.
Results: Administration of norepinephrine did not cause increases of both CD54 and CD106 in stimulated HUVEC.
Compared to negative controls the bacterial stimulation itself led to an increase of adhesion molecules. Following
administration of terbutaline no significant increase in CD54 expression was found.
Conclusions: Bacterial stimulation led to an increase of adhesion molecule expression. Adrenoceptor stimulation of
activated endothelial cells did not cause significant increases of cellular adhesion molecules.
Background
Endothelial cells are found in every vascularized tissue,
and form the inner lining of the vascular and capillary
wall. The main function of endothelial cells is to work
as a communicative barrier between intravascular and
extravascular spaces. Under physiologic conditions,
there are regular intercellular and transcellular routes of
transport of corpuscular and noncorpuscular agents
from the luminal site to the abluminal site [1]. Contact
and communication among cells either from identical or
different types and sites depend on receptors and adhe-
sion molecules anchored in the membrane of the cell.
Adhesion molecules are mediators between cells. Dur-
ing inflammation, ELAM-1 (E-selectin), intercellular
adhesion molecule 1 (ICAM-1 (CD54)) and vascular
adhesion molecule 1 (VCAM-1 (CD106)) are important
for the interaction with peripheral blood cells. After bac-
terial invasion, cytokines like IL-1b or TNF-alpha, as
produced in tissue macrophages, cause E-selectin
expression on endothelial surfaces. Following own selec-
tin expression, white blood cells start rolling on
endothelial surface which means deceleration and initia-
tion of adherence. On the endothelial surface, ICAM-1
interacts with MAC-1 (= b-integrin) surface molecule of
leukocytes. Contacts amongst endothelial cells and to
monocytes or lymphocytes are mediated via endothelial
VCAM-1 (CD106) and leukocytes surface molecule
VLA-4. Upon activation, these adhesion molecules can
be sledded from the cell surface and released into circu-
lation [2].
During sepsis and multiple trauma physiological
homeostasis mechanisms are disturbed. Patients fre-
quently need pharmaceutical or mechanical organ func-
tion support. Hypodynamic or hyperdynamic circulatory
dysregulation frequently require adrenoceptor agonist
therapy. Under stimulation of b2 adrenoceptors, reduced
adherence of NK-cells [3], increased vasorelaxation [4],
and reduced extravasation of fluids were observed.
Besides treating the underlying condition, microvascular
resuscitation is a crucial part of sepsis treatment [5].
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adhesion molecules is influenced by the use of norepi-
nephrine or terbutaline, as t h i sm a yb ed e t r i m e n t a lo r
beneficial during sepsis. We therefore examined the ex
vivo effects of b1o rb2 stimulation on adhesion mole-
cule expression in human endothelial cells by flow
cytometry.
The questions especially addressed were: Is there an
altered expression of adhesion molecules ICAM-1 or
VCAM-1 by administration of a bacterial stimulus, or
by the adrenoceptor agonist, or by both?
Methods
Cell preparation and cell culture
Cells were harvested using 0.04% collagenase (in PBS/
MgCl2 solution) from human umbilical cords. After cen-
trifugation the cell pellets were put into 5 ml medium
(Endothelmedium, PromoCell, Heidelberg, Germany),
given into culture flasks and incubated at 37°C and 5%
CO2 (Incubator: Queue, Nunc, Wiesbaden, Germany).
Cells were trypsinized and re-seeded at roughly 90%
confluence. After the second or third passage, cells were
used for stimulation and investigation of both b1 agonist
and b2 agonist effects.
Experimental setting
Cells were stimulated overnight for 16 to 20 hours in
the incubator (37°C, 5% CO2)b ya d d i n gE. coli (3 × 10
7
×m l
-1) (H 101, grown in Hannover Medical School’s
own laboratory).
After washing the cells with Ly-PBS (Hannover Medi-
cal School), 50 μl trypsin EDTA (Biochrom, Berlin, Ger-
many) were given for detachment of the cells. Then, the
cells were washed twice. Finally, 5 μl of norepinephrine
(Sigma Aldrich, Taufkirchen, Germany) or 10 μlt e r b u -
taline (Sigma Aldrich, Taufkirchen, Germany) in 500 μl
Ly-PBS buffer were administered both at concentrations
of 10
-7 M at a pH of 7.4. After 20 minutes’ the incuba-
tions were stopped. 10 μl of each antibody (ICAM-1, i.e.
CD54, Beckman Coulter, Krefeld, Germany; VCAM-1, i.
e. CD106 Serotec, Düsseldorf, Germany) both marked
with the green fluorescent fluorescein isothiocyanate
(FITC) were added. 20 μl of the red fluorescent propi-
dium iodide (PI; Sigma Aldrich, Taufkirchen, Germany)
to stain DNA of dead cells, which should be excluded
from our calculation, were also added. After 30 minutes
of incubation (room temperature, dark) each tube again
was centrifuged (4°C, 2000 rpm, 5 min) and the super-
natant decanted to remove eventual detached adhesion
molecules and antibodies. Cells were resuspended in
750 μl binding buffer solution, put into FACS tubes
(Sarstedt, Nürnberg, Germany) on ice and then analysed
flowcytometrically (EPICS XL, Beckman Coulter, Kre-
feld, Germany).
FACS analysis
10,000 events per assay were measured after PI positive,
i.e. dead, cells had been excluded. Events were depicted
in dot plot diagrams to analyse the number of all events
as a qualitative parameter. A life gate was then drawn
around the HUVEC population. In a histogram the
mean fluorescence of events as a quantitative parameter
to analyse the distribution of a marked characteristic
was registered.
Data collection and statistical analysis
All measurements were collected in an Excel (Microsoft)
d a t a b a s ea n da n a l y s e dw i t hS P S S( 1 1 . 0 ) ,p<0 . 0 5w a s
considered significant. All numeric data showed a Gaus-
sian distribution (Kolmogorov-Smirnov-Test), so the
univariate analysis of variance (ANOVA) (Fischer’s exact
test) was used to compare various concentrations of
either b1o rb2 agonistic substances. Because not all the
measurement showed skewness |g| ≤ 0.4, differences in
adhesion molecule expression were compared in a
paired Wilcoxon test. Correlation of quality (percent sti-
mulation) and quantity (mean fluorescence) was calcu-
lated with correlation coefficient (Pearson).
Results are presented as mean and standard error of
mean (mean ± SEM percentage). Results were depicted
as histograms reproducing the mean fluorescence which
means quantitative adhesion molecule expression. We
also calculated the relationships of norepinephrine
administration compared to the baseline values which
were depicted as box plots.
Results
HUVEC were investigated if there was a change in
expression of the cellular adhesion molecules ICAM-1
a n dV C A M - 1c a u s e db ye i t h e rt h eb1-stimulating agent
norepinephrine or the b2-agonist terbutaline with and
without bacterial stimulation with E. coli.
Compared to negative controls (ICAM-1: 2.74 ± 0.18;
VCAM-1: 3.76 ± 0.13), bacterial stimulation of HUVEC
and additional norepinephrine administration caused a
significant increase in ICAM-1 expression up to 20.64 ±
2.88 and also a significant increase in VCAM-1 expres-
sion up to 5.73 ± 0.41 (Figures 1 &2). Norepinephrine
administration without bacterial stimulation did not
cause relevant increases in adhesion molecule expression
(ICAM-1: 2.76 ± 0.67; VCAM-1: 3.72 ± 0.18). Norepi-
nephrine administration onto the stimulated cells caused
significant effects in ICAM-1 expressions compared to
negative controls, but roughly remained at levels as
caused by bacterial stimulation only (ICAM-1: 19.81 ±
2.53; VCAM-1: 5.30 ± 0.37). Administration of terbuta-
line (Figures 3 &4) did not cause increases in both adhe-
sion molecules investigated (negative controls 4.07 ±
0.46 in ICAM-1, and 4.42 ± 0.59 in VCAM-1,
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4.80 ± 0.71 in VCAM-1, respectively). Mere bacterial
challenge led to significant increases of both adhesion
molecules’ expressions compared to negative controls
(11.72 ± 2.09 in ICAM-1, and 8.78 ± 0.95 in VCAM-1)
a n dc o m p a r e dt ob2 stimulation. These increases were
even stronger under the combined administration of ter-
butaline and E. coli, the results were significant as com-
pared to controls and to the b2 stimulation (30.91 ±
11.93 in ICAM-1, and 9.33 ± 1.13 in VCAM-1), but not
when compared to bacterial stimulation.
Discussion
Endothelial cells can attract and bind immunocompe-
tent cells, and are involved in host defence. Stimuli
like bacteria or ischemia can also induce an exagger-
ated expression and release of adhesion molecules [6,7]
leading to a loss of shape and function of the endothe-
lial cell layer, capillary leakage and development of
interstitial oedema which may be either a cause or a
consequence of microcirculation disorders. Clinical
presentation of the systemic inflammatory response
syndrome (SIRS) includes tachycardia, hypotension,
fever, and respiratory insufficiency. Intensive care ther-
apy is required in these patients to restore and main-
tain tissue perfusion and oxygenation. Treatment often
remains limited to symptomatic therapy as the focus
or other causes of this overwhelming reaction cannot
definitely be found in many cases. Treatment includes
volume replacement and vasopressor therapy for circu-
latory and microvascular resuscitation [5]. Glucocorti-
coids are often administered to reduce inflammatory
activity, but have not been shown to reduce levels of
soluble adhesion molecules in septic patients [8]. Adre-
noceptor agonist drugs are almost regularly adminis-
tered in the treatment of septic patients during
intensive care therapy. Norepinephrine is given to
maintain circulation in terms of increasing vascular
resistance and organ perfusion. In case a patient suf-
fers from bronchial obstruction, b2a g o n i s t ss u c ha s
terbutaline can be given to improve ventilation.
Terbutaline as well as norepinephrine influence the
properties of activated endothelial cells in vitro and in
vivo: While norepinephrine led to an increase of inter-
leukin-6 synthesis in LPS activated endothelial cells
that was mediated by b1-receptors [9], terbutaline
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Figure 1 Quantitative changes in CD 54 (ICAM-1) expression
following norepinephrine (b1) and bacterial (E. coli)
stimulation. *statistical analysis p = 0.001, versus negative control
and versus b1 stimulation, Wilcoxon test. (The box represents the
mid 50% range of the data. Whiskers are the lines that extend
outwards from the ends of the box to a distance of at most 1.5
units of interquartile range.)
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Figure 2 Quantitative changes in CD 106 (VCAM-1) expression
following norepinephrine (b1) and bacterial (E.coli) stimulation.
*statistical analysis p ≤ 0.001, versus negative control and versus b1
stimulation, Wilcoxon test. (The box represents the mid 50% range
of the data. Whiskers are the lines that extend outwards from the
ends of the box to a distance of at most 1.5 units of interquartile
range.)
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enhanced leukocyte rolling on endothelial cells [10].
Endothelial adhesion molecules are crucial in mediat-
ing innate and acquired immunity. During general sys-
temic inflammation, Law et al. [11] described a
connection between multiple organ failure and increased
levels of soluble ICAM-1 in peripheral blood of patients
following multiple trauma in a group of 13 individuals.
Sessler [12] also found increased levels of circulating
ICAM-1 levels in patients with septic shock. Further-
more, ICAM-1 deficient mice were less prone to septic
shock than mice without any genetic manipulation
[13-15] which indicates the important role of ICAM-1
in conditions such as sepsis. Like Cowley et al. [16],
Vargas Hein et al. [ 2 ]d e m o n s t r a t e dt h a te l e v a t e d
sELAM-1 levels were corresponding with unfavourable
outcomes of severe sepsis. sICAM-1 levels were not sig-
nificantly different between survivors and non-survivors.
Carlson et al. showed in an in vitro experiment a
reduced T-cell binding to activated endothelial cells
after catecholamine application, this decrease however
did not seem to be mediated by a change in adhesion
molecule expression on either leukocytes or endothelial
cells [17]. These effects may at least partly be mediated
by a b1a n db2 induced increase of intracellular cAMP
levels. Changes in transcription rates as a result of an
increase of intracellular cAMP have been described for a
variety of cells [18]. Investigation in the specific effects
of increased cAMP levels on endothelial adhesion mole-
cule expression did not lead to clear results. While
Pober et al. found a reduced adhesion molecule expres-
sion after increasing cAMP levels in TNFa activated
endothelial cells [19], other groups did not find effects
of changes in cAMP concentrations on adhesion mole-
cule expression [20,10]. Regarding the transcription level
of adhesion molecules, expression is related to an
increased activation of the transcription factor NF-B
[21]. Bacterial heat shock proteins also lead to an
increased expression of cytokine and adhesion molecule
expression in monocytes and endothelial cells [22].
As the interaction between adrenoceptor stimulation
and adhesion molecule expression on stimulated
endothelial cells has not been entirely clarified, our group
investigated if b-adrenoceptor agonist administration
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Figure 3 Quantitative changes in CD 54 (ICAM-1) expression
following terbutaline (b2) and bacterial (E.coli) stimulation.
*statistical analysis p ≤ 0.001, versus negative control and versus b2
stimulation, Wilcoxon test. (The box represents the mid 50% range
of the data. Whiskers are the lines that extend outwards from the
ends of the box to a distance of at most 1.5 units of interquartile
range.)
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Figure 4 Quantitative changes in CD 106 (VCAM-1) expression
following terbutaline (b2) and bacterial (E.coli) stimulation.
*statistical analysis p ≤ 0.001, versus negative control and versus b2
stimulation, Wilcoxon test. (The box represents the mid 50% range
of the data. Whiskers are the lines that extend outwards from the
ends of the box to a distance of at most 1.5 units of interquartile
range.)
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adhesion molecules (ICAM-1) and vascular adhesion
molecules (VCAM-1) in human umbilical cord
endothelial cells (HUVEC). Bacterial activation with E.
coli itself caused significant increases in the expression
of both adhesion molecules. Whereas b1 adrenoceptor
stimulation with norepinephrine did not cause further
increases, b2 stimulation with terbutaline led to
a further increase in both ICAM-1 and VCAM-1
expressions.
Other groups have investigated different cell types
such as pulmonary microvasculature cells [23] or differ-
ent stimulation mechanisms and found evidence for
migration of polymorphonuclear neutrophils mediated
by endothelial adhesion molecules. Our method repre-
sents an isolated in vitro assay. Factors like underlying
and concomitant diseases and their treatment are influ-
encing adhesion molecule formation and release. We
were interested if effects of other agents which are fre-
quently used could be observed and lead to changed
opinions and therapeutic consequences. In preliminary
experiments we determined the optimal concentrations
of stimulation and adrenoceptor treatment. Starting
with either adrenoceptor or bacterial stimulation did not
reveal different results.
We found an effect of bacterial stimulation on
ICAM-1 and VCAM-1 adhesion molecule expression
which was not markedly influenced neither by admin-
istration of the b1-adrenergic agent norepinephrine
nor the b2-adrenergic agent terbutaline. In summary,
adrenoceptor stimulation did not lead to further altera-
tions. We have not examined soluble adhesion mole-
cules which may represent a higher proportion of
formerly expressed and then detached cells released
into the assay or into the bloodstream as shown by
other groups [6-8].
Conclusions
Endothelial adhesion molecules ICAM-1 and VCAM-1
were increased following bacterial stimulation. Adminis-
tration of adrenoceptor-stimulating substances did not
lead to significant increases in stimulated or non-stimu-
lated cells.
In forthcoming studies, the influence of adrenoceptor
agonists on endothelial adhesion molecule release will
be further investigated.
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